Header Logo

Connection

Robert Axtell to Mice

Back to Details
This is a "connection" page, showing publications Robert Axtell has written about Mice.
Robert Axtell
Connection Strength
1.274
Mice
  1. Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE. Int J Mol Sci. 2021 Mar 13; 22(6).
    View in: PubMed
    Score: 0.097
  2. CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS. Neurol Neuroimmunol Neuroinflamm. 2021 05; 8(3).
    View in: PubMed
    Score: 0.096
  3. ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model. Mult Scler Relat Disord. 2021 Apr; 49:102786.
    View in: PubMed
    Score: 0.096
  4. Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica. Nat Commun. 2020 06 05; 11(1):2856.
    View in: PubMed
    Score: 0.092
  5. B cell function impacts the efficacy of IFN-ß therapy in EAE. J Neuroimmunol. 2020 01 15; 338:577106.
    View in: PubMed
    Score: 0.088
  6. Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. Front Immunol. 2018; 9:382.
    View in: PubMed
    Score: 0.078
  7. IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
    View in: PubMed
    Score: 0.063
  8. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin Rev Allergy Immunol. 2013 Apr; 44(2):114-20.
    View in: PubMed
    Score: 0.056
  9. Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler. 2012 Apr; 18(4):398-408.
    View in: PubMed
    Score: 0.052
  10. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010 Apr; 16(4):406-12.
    View in: PubMed
    Score: 0.045
  11. Type 1 interferons cool the inflamed brain. Immunity. 2008 May; 28(5):600-2.
    View in: PubMed
    Score: 0.040
  12. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J Immunol. 2006 Dec 15; 177(12):8542-9.
    View in: PubMed
    Score: 0.036
  13. Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. J Immunol. 2004 Sep 01; 173(5):2928-32.
    View in: PubMed
    Score: 0.031
  14. Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival. Theranostics. 2022; 12(2):639-656.
    View in: PubMed
    Score: 0.026
  15. E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation. J Immunol. 2020 08 15; 205(4):1009-1023.
    View in: PubMed
    Score: 0.023
  16. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. J Autoimmun. 2020 01; 106:102332.
    View in: PubMed
    Score: 0.022
  17. Immunization-Expanded NKT Follicular Helper Cells Drive IgG1 Isotype Switch against an Exogenous T-Independent Polysaccharide but Do Not Promote Recall Responses. Immunohorizons. 2019 03; 3(3):88-93.
    View in: PubMed
    Score: 0.021
  18. Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol. 2017 12 15; 313:77-81.
    View in: PubMed
    Score: 0.019
  19. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice. Mol Vis. 2016; 22:332-41.
    View in: PubMed
    Score: 0.017
  20. mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function. J Immunol. 2015 Aug 15; 195(4):1470-9.
    View in: PubMed
    Score: 0.016
  21. B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci. 2015 Feb 04; 35(5):2133-45.
    View in: PubMed
    Score: 0.016
  22. Astrocytic TGF-ß signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J Immunol. 2014 Jul 01; 193(1):139-49.
    View in: PubMed
    Score: 0.015
  23. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov; 14(11):1166-72.
    View in: PubMed
    Score: 0.014
  24. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2013 Sep 15; 191(6):2967-77.
    View in: PubMed
    Score: 0.014
  25. Th17 cells induce Th1-polarizing monocyte-derived dendritic cells. J Immunol. 2013 Aug 01; 191(3):1175-87.
    View in: PubMed
    Score: 0.014
  26. Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest. 2013 Jun; 123(6):2447-63.
    View in: PubMed
    Score: 0.014
  27. CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. J Immunol. 2012 Sep 15; 189(6):2918-30.
    View in: PubMed
    Score: 0.013
  28. Reversal of paralysis and reduced inflammation from peripheral administration of ß-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Sci Transl Med. 2012 Aug 01; 4(145):145ra105.
    View in: PubMed
    Score: 0.013
  29. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J Exp Med. 2012 Jul 02; 209(7):1325-34.
    View in: PubMed
    Score: 0.013
  30. Therapeutic effects of systemic administration of chaperone aB-crystallin associated with binding proinflammatory plasma proteins. J Biol Chem. 2012 Mar 23; 287(13):9708-9721.
    View in: PubMed
    Score: 0.013
  31. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model. J Heart Lung Transplant. 2011 Dec; 30(12):1409-17.
    View in: PubMed
    Score: 0.013
  32. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation. 2011 Sep 13; 124(11 Suppl):S187-96.
    View in: PubMed
    Score: 0.013
  33. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011 10; 19(10):1769-79.
    View in: PubMed
    Score: 0.013
  34. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-ß in multiple sclerosis. Sci Transl Med. 2011 Jul 27; 3(93):93ra68.
    View in: PubMed
    Score: 0.012
  35. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J Exp Med. 2010 Aug 02; 207(8):1599-608.
    View in: PubMed
    Score: 0.012
  36. Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest. 2010 Aug; 120(8):2782-94.
    View in: PubMed
    Score: 0.012
  37. IL-17 contributes to the development of chronic rejection in a murine heart transplant model. J Clin Immunol. 2010 Mar; 30(2):235-40.
    View in: PubMed
    Score: 0.011
  38. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A. 2010 Feb 09; 107(6):2580-5.
    View in: PubMed
    Score: 0.011
  39. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2008 Jul 01; 181(1):338-45.
    View in: PubMed
    Score: 0.010
  40. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J Immunol. 2005 Nov 15; 175(10):6327-33.
    View in: PubMed
    Score: 0.008
  41. AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells. J Immunol. 2002 Jun 01; 168(11):5612-20.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.